ALZN financials

Alzamend Neuro (ALZN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

ALZN income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2026––-$8.77M-$8.77M-2.63
2025––-$4.50M-$5.11M-11.32
2024––-$9.94M-$9.95M-132.33
2023––-$14.87M-$14.88M-228.90
2022––-$12.32M-$12.36M-21.00
2021––-$4.95M-$5.05M-10.50